{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:09:07Z","timestamp":1778429347314,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":66,"publisher":"Springer US","isbn-type":[{"value":"9781071647493","type":"print"},{"value":"9781071647509","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4750-9_13","type":"book-chapter","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T13:07:09Z","timestamp":1756559229000},"page":"231-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chromoanagenesis Detection in Chronic Lymphocytic Leukemia"],"prefix":"10.1007","author":[{"given":"Silvia","family":"Ramos-Campoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Kamaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Puiggros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Espinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"issue":"7","key":"13_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, IBO A, Berti E et al (2022) The 5th edition of the World Health Organization classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748","journal-title":"Leukemia"},{"issue":"11","key":"13_CR2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140(11):1229\u20131253","journal-title":"Blood"},{"issue":"1","key":"13_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","volume":"32","author":"B Eichhorst","year":"2021","unstructured":"Eichhorst B, Robak T, Montserrat E et al (2021) ESMO guidelines committee. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(1):23\u201333","journal-title":"Ann Oncol"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"14175","DOI":"10.1038\/ncomms14175","volume":"8","author":"PJ Law","year":"2017","unstructured":"Law PJ, Berndt SI, Speedy HE et al (2017) Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun 8:14175","journal-title":"Nat Commun"},{"issue":"1","key":"13_CR5","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1038\/s41467-019-11582-2","volume":"10","author":"HE Speedy","year":"2019","unstructured":"Speedy HE, Beekman R et al (2019) Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics. Nat Commun 10(1):3615","journal-title":"Nat Commun"},{"issue":"25","key":"13_CR6","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D et al (2018) iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131(25):2745\u20132760","journal-title":"Blood"},{"issue":"1","key":"13_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cyto.b.21595","volume":"94","author":"AC Rawstron","year":"2018","unstructured":"Rawstron AC, Kreuzer KA, Soosapilla A et al (2018) Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) harmonisation project. Cytometry B Clin Cytom 94(1):121\u2013128","journal-title":"Cytometry B Clin Cytom"},{"issue":"8","key":"13_CR8","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/cancers13081782","volume":"13","author":"I Gonz\u00e1lez-Gasc\u00f3n-Y-Mar\u00edn","year":"2021","unstructured":"Gonz\u00e1lez-Gasc\u00f3n-Y-Mar\u00edn I, Mu\u00f1oz-Novas C, Rodr\u00edguez-Vicente AE et al (2021) From biomarkers to models in the changing landscape of chronic lymphocytic leukemia: evolve or become extinct. Cancers (Basel) 13(8):1782","journal-title":"Cancers (Basel)"},{"key":"13_CR9","first-page":"OP2300770","volume":"7","author":"BD Cheson","year":"2024","unstructured":"Cheson BD, Sharman JP (2024) Current approaches and novel new agents in the treatment of chronic lymphocytic leukemia. JCO Oncol Pract 7:OP2300770","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"13_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP et al (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46(2):219\u2013234","journal-title":"Blood"},{"issue":"1","key":"13_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"JL Binet","year":"1981","unstructured":"Binet JL, Auquier A, Dighiero G et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48(1):198\u2013206","journal-title":"Cancer"},{"issue":"26","key":"13_CR12","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343(26):1910\u20131926","journal-title":"N Engl J Med"},{"issue":"17","key":"13_CR13","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","volume":"127","author":"F Nadeu","year":"2016","unstructured":"Nadeu F, Delgado J, Royo C et al (2016) Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia. Blood 127(17):2122\u20132130","journal-title":"Blood"},{"issue":"6","key":"13_CR14","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94(6):1840\u20131847","journal-title":"Blood"},{"issue":"6","key":"13_CR15","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A et al (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94(6):1848\u20131854","journal-title":"Blood"},{"issue":"11","key":"13_CR16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1056\/NEJM199009133231105","volume":"323","author":"G Juliusson","year":"1990","unstructured":"Juliusson G, Oscier DG, Fitchett M et al (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323(11):720\u2013724","journal-title":"N Engl J Med"},{"issue":"12","key":"13_CR17","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","volume":"21","author":"C Haferlach","year":"2007","unstructured":"Haferlach C, Dicker F, Schnittger S et al (2007) Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 21(12):2442\u20132451","journal-title":"Leukemia"},{"issue":"11","key":"13_CR18","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1182\/blood-2010-08-304683","volume":"117","author":"XC Badoux","year":"2011","unstructured":"Badoux XC, Keating MJ, Wang X et al (2011) Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL. Blood 117(11):3016\u20133024","journal-title":"Blood"},{"issue":"3","key":"13_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ajh.23618","volume":"89","author":"P Baliakas","year":"2014","unstructured":"Baliakas P, Iskas M, Gardiner A et al (2014) Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data. Am J Hematol 89(3):249\u2013255","journal-title":"Am J Hematol"},{"issue":"33","key":"13_CR20","doi-asserted-by":"publisher","first-page":"54297","DOI":"10.18632\/oncotarget.17350","volume":"8","author":"A Puiggros","year":"2017","unstructured":"Puiggros A, Collado R, Calasanz MJ et al (2017) Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53\/ATM FISH deletions. Oncotarget 8(33):54297\u201354303","journal-title":"Oncotarget"},{"issue":"11","key":"13_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","volume":"133","author":"P Baliakas","year":"2019","unstructured":"Baliakas P, Jeromin S, Iskas M et al (2019) ERIC, the European research initiative on CLL. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. Blood 133(11):1205\u20131216","journal-title":"Blood"},{"issue":"76","key":"13_CR22","doi-asserted-by":"publisher","first-page":"34398","DOI":"10.18632\/oncotarget.26146","volume":"9","author":"M Cavallari","year":"2018","unstructured":"Cavallari M, Cavazzini F, Bardi A et al (2018) Biological significance and prognostic\/predictive impact of complex karyotype in chronic lymphocytic leukemia. Oncotarget 9(76):34398\u201334412","journal-title":"Oncotarget"},{"issue":"49","key":"13_CR23","doi-asserted-by":"publisher","first-page":"80916","DOI":"10.18632\/oncotarget.13106","volume":"7","author":"G Blanco","year":"2016","unstructured":"Blanco G, Puiggros A, Baliakas P et al (2016) Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations. Oncotarget 7(49):80916\u201380924","journal-title":"Oncotarget"},{"issue":"3","key":"13_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1182\/blood-2016-01-691550","volume":"128","author":"CD Herling","year":"2016","unstructured":"Herling CD, Klaum\u00fcnzer M, Rocha CK et al (2016) Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy. Blood 128(3):395\u2013404","journal-title":"Blood"},{"issue":"2","key":"13_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hon.2025","volume":"31","author":"A Travella","year":"2013","unstructured":"Travella A, Ripoll\u00e9s L, Aventin A et al (2013) Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis. Hematol Oncol 31(2):79\u201387","journal-title":"Hematol Oncol"},{"issue":"7","key":"13_CR26","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.3324\/haematol.2015.140202","volume":"101","author":"P Baliakas","year":"2016","unstructured":"Baliakas P, Puiggros A, Xochelli A et al (2016) Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference. Haematologica 101(7):e299\u2013e302","journal-title":"Haematologica"},{"issue":"2","key":"13_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2005-05-2093","volume":"107","author":"C Mayr","year":"2006","unstructured":"Mayr C, Speicher MR, Kofler DM et al (2006) Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107(2):742\u2013751","journal-title":"Blood"},{"issue":"2","key":"13_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/bjh.15174","volume":"181","author":"GM Rigolin","year":"2018","unstructured":"Rigolin GM, Saccenti E, Guardalben E et al (2018) In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics. Br J Haematol 181(2):229\u2013233","journal-title":"Br J Haematol"},{"issue":"1","key":"13_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2141.2012.09239.x","volume":"159","author":"SM Jaglowski","year":"2012","unstructured":"Jaglowski SM, Ruppert AS, Heerema NA et al (2012) Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia. Br J Haematol 159(1):82\u201387","journal-title":"Br J Haematol"},{"issue":"4","key":"13_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/hon.2349","volume":"35","author":"Y Le Bris","year":"2017","unstructured":"Le Bris Y, Struski S, Gui\u00e8ze R et al (2017) Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia. Hematol Oncol 35(4):664\u2013670","journal-title":"Hematol Oncol"},{"issue":"20","key":"13_CR31","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1002\/cncr.29566","volume":"121","author":"PA Thompson","year":"2015","unstructured":"Thompson PA, O\u2019Brien SM, Wierda WG et al (2015) Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens. Cancer 121(20):3612\u20133621","journal-title":"Cancer"},{"issue":"25","key":"13_CR32","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1182\/blood-2017-01-763003","volume":"129","author":"MA Anderson","year":"2017","unstructured":"Anderson MA, Tam C, Lew TE et al (2017) Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax. Blood 129(25):3362\u20133370","journal-title":"Blood"},{"issue":"1","key":"13_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/leu.2017.175","volume":"32","author":"JR Brown","year":"2018","unstructured":"Brown JR, Hillmen P, O\u2019Brien S et al (2018) Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL\/SLL. Leukemia 32(1):83\u201391","journal-title":"Leukemia"},{"issue":"9","key":"13_CR34","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S1470-2045(20)30443-5","volume":"21","author":"O Al-Sawaf","year":"2020","unstructured":"Al-Sawaf O, Zhang C, Tandon M et al (2020) Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 21(9):1188\u20131200","journal-title":"Lancet Oncol"},{"issue":"15","key":"13_CR35","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1182\/blood.2018884940","volume":"135","author":"JC Byrd","year":"2020","unstructured":"Byrd JC, Wierda WG, Schuh A et al (2020) Acalabrutinib monotherapy in patients with relapsed\/refractory chronic lymphocytic leukemia: updated phase 2 results. Blood 135(15):1204\u20131213","journal-title":"Blood"},{"issue":"23","key":"13_CR36","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1182\/blood.2020010536","volume":"138","author":"AS Kittai","year":"2021","unstructured":"Kittai AS, Miller C, Goldstein D et al (2021) The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib. Blood 138(23):2372\u20132382","journal-title":"Blood"},{"issue":"25","key":"13_CR37","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1182\/blood.2021011883","volume":"138","author":"GM Rigolin","year":"2021","unstructured":"Rigolin GM, Del Giudice I, Bardi A et al (2021) Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study. Blood 138(25):2727\u20132730","journal-title":"Blood"},{"issue":"5","key":"13_CR38","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1182\/blood.2023019634","volume":"142","author":"M F\u00fcrstenau","year":"2023","unstructured":"F\u00fcrstenau M, Thus YJ, Robrecht S et al (2023) High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations. Blood 142(5):446\u2013459","journal-title":"Blood"},{"issue":"5","key":"13_CR39","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1182\/blood-2007-07-099432","volume":"112","author":"L Kujawski","year":"2008","unstructured":"Kujawski L, Ouillette P, Erba H et al (2008) Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia. Blood 112(5):1993\u20132003","journal-title":"Blood"},{"issue":"11","key":"13_CR40","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2010-12-327858","volume":"118","author":"P Ouillette","year":"2011","unstructured":"Ouillette P, Collins R, Shakhan S et al (2011) Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia. Blood 118(11):3051\u20133061","journal-title":"Blood"},{"issue":"1","key":"13_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3324\/haematol.2019.239947","volume":"106","author":"AC Leeksma","year":"2021","unstructured":"Leeksma AC, Baliakas P, Moysiadis T et al (2021) Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study. Haematologica 106(1):87\u201397","journal-title":"Haematologica"},{"issue":"3","key":"13_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3324\/haematol.2020.274456","volume":"107","author":"S Ramos-Campoy","year":"2022","unstructured":"Ramos-Campoy S, Puiggros A, Be\u00e0 S et al (2022) Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients. Haematologica 107(3):593\u2013603","journal-title":"Haematologica"},{"issue":"34","key":"13_CR43","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1200\/JCO.20.00948","volume":"38","author":"AP Kater","year":"2020","unstructured":"Kater AP, Wu JQ, Kipps T et al (2020) Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study. J Clin Oncol 38(34):4042\u20134054","journal-title":"J Clin Oncol"},{"issue":"1","key":"13_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","volume":"144","author":"PJ Stephens","year":"2011","unstructured":"Stephens PJ, Greenman CD, Fu B et al (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144(1):27\u201340","journal-title":"Cell"},{"issue":"12","key":"13_CR45","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/leu.2013.127","volume":"27","author":"L Bassaganyas","year":"2013","unstructured":"Bassaganyas L, Be\u00e0 S, Escaram\u00eds G et al (2013) Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis. Leukemia 27(12):2376\u20132379","journal-title":"Leukemia"},{"issue":"7574","key":"13_CR46","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente XS, Be\u00e0 S, Vald\u00e9s-Mas R et al (2015) Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526(7574):519\u2013524","journal-title":"Nature"},{"issue":"11","key":"13_CR47","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/leu.2016.134","volume":"30","author":"H Parker","year":"2016","unstructured":"Parker H, Rose-Zerilli MJ, Larr\u00e1yoz M et al (2016) Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia. Leukemia 30(11):2179\u20132186","journal-title":"Leukemia"},{"issue":"2","key":"13_CR48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/leu.2017.177","volume":"32","author":"A Burns","year":"2018","unstructured":"Burns A, Alsolami R, Becq J et al (2018) Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups. Leukemia 32(2):332\u2013342","journal-title":"Leukemia"},{"issue":"3","key":"13_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","volume":"52","author":"I Cort\u00e9s-Ciriano","year":"2020","unstructured":"Cort\u00e9s-Ciriano I, Lee JJ, Xi R et al (2020) PCAWG consortium. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet 52(3):331\u2013341","journal-title":"Nat Genet"},{"issue":"6","key":"13_CR50","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2013.02.023","volume":"152","author":"JO Korbel","year":"2013","unstructured":"Korbel JO, Campbell PJ (2013) Criteria for inference of chromothripsis in cancer genomes. Cell 152(6):1226\u20131236","journal-title":"Cell"},{"issue":"24","key":"13_CR51","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1182\/blood-2012-04-423517","volume":"120","author":"J Edelmann","year":"2012","unstructured":"Edelmann J, Holzmann K, Miller F et al (2012) High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 120(24):4783\u20134794","journal-title":"Blood"},{"issue":"1","key":"13_CR52","first-page":"4","volume":"1","author":"J Pei","year":"2012","unstructured":"Pei J, Jhanwar SC, Testa JR (2012) Chromothripsis in a case of TP53-deficient chronic lymphocytic leukemia. Leuk Res Rep 1(1):4\u20136","journal-title":"Leuk Res Rep"},{"issue":"7","key":"13_CR53","doi-asserted-by":"publisher","first-page":"985","DOI":"10.4103\/0366-6999.154329","volume":"128","author":"L Tan","year":"2015","unstructured":"Tan L, Xu LH, Liu HB et al (2015) Small lymphocytic lymphoma\/chronic lymphocytic leukemia with chromothripsis in an old woman. Chin Med J (Engl) 128(7):985\u2013987","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"13_CR54","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/gcc.22277","volume":"54","author":"I Salaverria","year":"2015","unstructured":"Salaverria I, Mart\u00edn-Garcia D, L\u00f3pez C et al (2015) Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia. Genes Chromosomes Cancer 54(11):668\u2013680","journal-title":"Genes Chromosomes Cancer"},{"issue":"15","key":"13_CR55","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.3390\/cancers14153715","volume":"14","author":"S Ramos-Campoy","year":"2022","unstructured":"Ramos-Campoy S, Puiggros A, Kamaso J et al (2022) TP53 abnormalities are underlying the poor outcome associated with Chromothripsis in chronic lymphocytic leukemia patients with complex karyotype. Cancers (Basel) 14(15):3715","journal-title":"Cancers (Basel)"},{"issue":"12","key":"13_CR56","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/jcm12124110","volume":"12","author":"M Cennamo","year":"2023","unstructured":"Cennamo M, Sirocchi D, Giudici C et al (2023) A peculiar CLL case with complex chromosome 6 rearrangements and refinement of all breakpoints at the gene level by genomic Array: a case report. J Clin Med 12(12):4110","journal-title":"J Clin Med"},{"issue":"14","key":"13_CR57","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.3390\/cancers14143376","volume":"14","author":"A Puiggros","year":"2022","unstructured":"Puiggros A, Ramos-Campoy S, Kamaso J et al (2022) Optical genome mapping: a promising new tool to assess genomic complexity in chronic lymphocytic leukemia (CLL). Cancers (Basel) 14(14):3376","journal-title":"Cancers (Basel)"},{"key":"13_CR58","volume-title":"XX International Workshop on CLL. Boston, 6\u20139 October 2023","author":"J Kamaso","year":"2023","unstructured":"Kamaso J, Puiggros A, Garc\u00eda-Serra R et al (2023) Optical genome mapping and fluorescence in situ hybridization is the best combination to identify genomic complexity and TP53 deletions in CLL patients. In: XX International Workshop on CLL. Boston, 6\u20139 October 2023"},{"issue":"4","key":"13_CR59","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/cancers15041294","volume":"15","author":"A Valkama","year":"2023","unstructured":"Valkama A, Vorimo S, Kumpula TA et al (2023) Optical genome mapping as an alternative to FISH-based cytogenetic assessment in chronic lymphocytic leukemia. Cancers (Basel) 15(4):1294","journal-title":"Cancers (Basel)"},{"issue":"10","key":"13_CR60","doi-asserted-by":"publisher","first-page":"E604","DOI":"10.1002\/ajh.24852","volume":"92","author":"M Jarosova","year":"2017","unstructured":"Jarosova M, Hruba M, Oltova A et al (2017) Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients. Am J Hematol 92(10):E604\u2013E607","journal-title":"Am J Hematol"},{"issue":"3","key":"13_CR61","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","volume":"153","author":"SC Baca","year":"2013","unstructured":"Baca SC, Prandi D, Lawrence MS et al (2013) Punctuated evolution of prostate cancer genomes. Cell 153(3):666\u2013677","journal-title":"Cell"},{"issue":"5","key":"13_CR62","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccr.2013.04.025","volume":"23","author":"MM Shen","year":"2013","unstructured":"Shen MM (2013) Chromoplexy: a new category of complex rearrangements in the cancer genome. Cancer Cell 23(5):567\u2013569","journal-title":"Cancer Cell"},{"issue":"12","key":"13_CR63","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Martin-Garcia D, Clot G et al (2020) Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood 136(12):1419\u20131432","journal-title":"Blood"},{"issue":"11","key":"13_CR64","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1038\/s41375-020-0921-y","volume":"34","author":"CJ Neuse","year":"2020","unstructured":"Neuse CJ, Lomas OC, Schliemann C et al (2020) Genome instability in multiple myeloma. Leukemia 34(11):2887\u20132897","journal-title":"Leukemia"},{"issue":"1","key":"13_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/gcc.22994","volume":"61","author":"D Costa","year":"2022","unstructured":"Costa D, Granada I, Espinet B et al (2022) Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia. Genes Chromosomes Cancer 61(1):37\u201343","journal-title":"Genes Chromosomes Cancer"},{"issue":"S1","key":"13_CR66","first-page":"e104(P1715)","volume":"8","author":"A Puiggros","year":"2024","unstructured":"Puiggros A, Kamaso J, Salido M et al (2024) Optical genome mapping as a new tool to identify chromoanagenesis phenomena in hematological malignancies. EHA2024 hybrid congress. HemaSphere 8(S1):e104(P1715)","journal-title":"HemaSphere"}],"container-title":["Methods in Molecular Biology","Chromoanagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4750-9_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:02:28Z","timestamp":1778428948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4750-9_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647493","9781071647509"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4750-9_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"31 August 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}